The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Recombinant Human Thrombin for Surgical Hemostasis Market Research Report 2024
Synopsis
Recombinant Human Thrombin for Surgical Hemostasis is a medication or product that contains artificially produced human thrombin, which is used in surgical procedures to promote blood clotting and control bleeding. Thrombin is a protein involved in the blood clotting process, and when applied topically or locally during surgery, it helps to accelerate the formation of blood clots and stop bleeding. This product is commonly used in various surgical specialties, such as cardiovascular surgery, orthopedic surgery, and general surgery, to help achieve hemostasis and prevent excessive bleeding.
The global Recombinant Human Thrombin for Surgical Hemostasis market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Recombinant Human Thrombin for Surgical Hemostasis is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Recombinant Human Thrombin for Surgical Hemostasis is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Recombinant Human Thrombin for Surgical Hemostasis include Takeda, Bayer, CSL, Grifols, GE Healthcare, Hualan Biological, Haematologic Technologies, Pfizer, Octapharma, Omrix Biopharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Recombinant Human Thrombin for Surgical Hemostasis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Human Thrombin for Surgical Hemostasis.
The Recombinant Human Thrombin for Surgical Hemostasis market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Recombinant Human Thrombin for Surgical Hemostasis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Recombinant Human Thrombin for Surgical Hemostasis manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Takeda
Bayer
CSL
Grifols
GE Healthcare
Hualan Biological
Haematologic Technologies
Pfizer
Octapharma
Omrix Biopharmaceuticals
Shanghai RAAS
Segment by Type
Based Bovine
Based Human
Others
Segment by Application
Hospitals
Diagnostics & Clinics
Academic and Research Institute
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Recombinant Human Thrombin for Surgical Hemostasis manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Recombinant Human Thrombin for Surgical Hemostasis in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Recombinant Human Thrombin for Surgical Hemostasis is a medication or product that contains artificially produced human thrombin, which is used in surgical procedures to promote blood clotting and control bleeding. Thrombin is a protein involved in the blood clotting process, and when applied topically or locally during surgery, it helps to accelerate the formation of blood clots and stop bleeding. This product is commonly used in various surgical specialties, such as cardiovascular surgery, orthopedic surgery, and general surgery, to help achieve hemostasis and prevent excessive bleeding.
The global Recombinant Human Thrombin for Surgical Hemostasis market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Recombinant Human Thrombin for Surgical Hemostasis is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Recombinant Human Thrombin for Surgical Hemostasis is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Recombinant Human Thrombin for Surgical Hemostasis include Takeda, Bayer, CSL, Grifols, GE Healthcare, Hualan Biological, Haematologic Technologies, Pfizer, Octapharma, Omrix Biopharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Recombinant Human Thrombin for Surgical Hemostasis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Human Thrombin for Surgical Hemostasis.
The Recombinant Human Thrombin for Surgical Hemostasis market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Recombinant Human Thrombin for Surgical Hemostasis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Recombinant Human Thrombin for Surgical Hemostasis manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Takeda
Bayer
CSL
Grifols
GE Healthcare
Hualan Biological
Haematologic Technologies
Pfizer
Octapharma
Omrix Biopharmaceuticals
Shanghai RAAS
Segment by Type
Based Bovine
Based Human
Others
Segment by Application
Hospitals
Diagnostics & Clinics
Academic and Research Institute
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Recombinant Human Thrombin for Surgical Hemostasis manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Recombinant Human Thrombin for Surgical Hemostasis in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Recombinant Human Thrombin for Surgical Hemostasis Market Overview
1.1 Product Definition
1.2 Recombinant Human Thrombin for Surgical Hemostasis by Type
1.2.1 Global Recombinant Human Thrombin for Surgical Hemostasis Market Value Comparison by Type (2024-2030)
1.2.2 Based Bovine
1.2.3 Based Human
1.2.4 Others
1.3 Recombinant Human Thrombin for Surgical Hemostasis by Application
1.3.1 Global Recombinant Human Thrombin for Surgical Hemostasis Market Value by Application (2024-2030)
1.3.2 Hospitals
1.3.3 Diagnostics & Clinics
1.3.4 Academic and Research Institute
1.4 Global Recombinant Human Thrombin for Surgical Hemostasis Market Size Estimates and Forecasts
1.4.1 Global Recombinant Human Thrombin for Surgical Hemostasis Revenue 2019-2030
1.4.2 Global Recombinant Human Thrombin for Surgical Hemostasis Sales 2019-2030
1.4.3 Global Recombinant Human Thrombin for Surgical Hemostasis Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Recombinant Human Thrombin for Surgical Hemostasis Market Competition by Manufacturers
2.1 Global Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Manufacturers (2019-2024)
2.2 Global Recombinant Human Thrombin for Surgical Hemostasis Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Recombinant Human Thrombin for Surgical Hemostasis Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Recombinant Human Thrombin for Surgical Hemostasis, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Recombinant Human Thrombin for Surgical Hemostasis, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Recombinant Human Thrombin for Surgical Hemostasis, Product Type & Application
2.7 Global Key Manufacturers of Recombinant Human Thrombin for Surgical Hemostasis, Date of Enter into This Industry
2.8 Global Recombinant Human Thrombin for Surgical Hemostasis Market Competitive Situation and Trends
2.8.1 Global Recombinant Human Thrombin for Surgical Hemostasis Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Recombinant Human Thrombin for Surgical Hemostasis Players Market Share by Revenue
2.8.3 Global Recombinant Human Thrombin for Surgical Hemostasis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Recombinant Human Thrombin for Surgical Hemostasis Market Scenario by Region
3.1 Global Recombinant Human Thrombin for Surgical Hemostasis Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Recombinant Human Thrombin for Surgical Hemostasis Sales by Region: 2019-2030
3.2.1 Global Recombinant Human Thrombin for Surgical Hemostasis Sales by Region: 2019-2024
3.2.2 Global Recombinant Human Thrombin for Surgical Hemostasis Sales by Region: 2025-2030
3.3 Global Recombinant Human Thrombin for Surgical Hemostasis Revenue by Region: 2019-2030
3.3.1 Global Recombinant Human Thrombin for Surgical Hemostasis Revenue by Region: 2019-2024
3.3.2 Global Recombinant Human Thrombin for Surgical Hemostasis Revenue by Region: 2025-2030
3.4 North America Recombinant Human Thrombin for Surgical Hemostasis Market Facts & Figures by Country
3.4.1 North America Recombinant Human Thrombin for Surgical Hemostasis Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Recombinant Human Thrombin for Surgical Hemostasis Sales by Country (2019-2030)
3.4.3 North America Recombinant Human Thrombin for Surgical Hemostasis Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Recombinant Human Thrombin for Surgical Hemostasis Market Facts & Figures by Country
3.5.1 Europe Recombinant Human Thrombin for Surgical Hemostasis Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Recombinant Human Thrombin for Surgical Hemostasis Sales by Country (2019-2030)
3.5.3 Europe Recombinant Human Thrombin for Surgical Hemostasis Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Recombinant Human Thrombin for Surgical Hemostasis Market Facts & Figures by Region
3.6.1 Asia Pacific Recombinant Human Thrombin for Surgical Hemostasis Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Recombinant Human Thrombin for Surgical Hemostasis Sales by Region (2019-2030)
3.6.3 Asia Pacific Recombinant Human Thrombin for Surgical Hemostasis Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Recombinant Human Thrombin for Surgical Hemostasis Market Facts & Figures by Country
3.7.1 Latin America Recombinant Human Thrombin for Surgical Hemostasis Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Recombinant Human Thrombin for Surgical Hemostasis Sales by Country (2019-2030)
3.7.3 Latin America Recombinant Human Thrombin for Surgical Hemostasis Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Recombinant Human Thrombin for Surgical Hemostasis Market Facts & Figures by Country
3.8.1 Middle East and Africa Recombinant Human Thrombin for Surgical Hemostasis Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Recombinant Human Thrombin for Surgical Hemostasis Sales by Country (2019-2030)
3.8.3 Middle East and Africa Recombinant Human Thrombin for Surgical Hemostasis Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Recombinant Human Thrombin for Surgical Hemostasis Sales by Type (2019-2030)
4.1.1 Global Recombinant Human Thrombin for Surgical Hemostasis Sales by Type (2019-2024)
4.1.2 Global Recombinant Human Thrombin for Surgical Hemostasis Sales by Type (2025-2030)
4.1.3 Global Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Type (2019-2030)
4.2 Global Recombinant Human Thrombin for Surgical Hemostasis Revenue by Type (2019-2030)
4.2.1 Global Recombinant Human Thrombin for Surgical Hemostasis Revenue by Type (2019-2024)
4.2.2 Global Recombinant Human Thrombin for Surgical Hemostasis Revenue by Type (2025-2030)
4.2.3 Global Recombinant Human Thrombin for Surgical Hemostasis Revenue Market Share by Type (2019-2030)
4.3 Global Recombinant Human Thrombin for Surgical Hemostasis Price by Type (2019-2030)
5 Segment by Application
5.1 Global Recombinant Human Thrombin for Surgical Hemostasis Sales by Application (2019-2030)
5.1.1 Global Recombinant Human Thrombin for Surgical Hemostasis Sales by Application (2019-2024)
5.1.2 Global Recombinant Human Thrombin for Surgical Hemostasis Sales by Application (2025-2030)
5.1.3 Global Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Application (2019-2030)
5.2 Global Recombinant Human Thrombin for Surgical Hemostasis Revenue by Application (2019-2030)
5.2.1 Global Recombinant Human Thrombin for Surgical Hemostasis Revenue by Application (2019-2024)
5.2.2 Global Recombinant Human Thrombin for Surgical Hemostasis Revenue by Application (2025-2030)
5.2.3 Global Recombinant Human Thrombin for Surgical Hemostasis Revenue Market Share by Application (2019-2030)
5.3 Global Recombinant Human Thrombin for Surgical Hemostasis Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Takeda
6.1.1 Takeda Company Information
6.1.2 Takeda Description and Business Overview
6.1.3 Takeda Recombinant Human Thrombin for Surgical Hemostasis Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Takeda Recombinant Human Thrombin for Surgical Hemostasis Product Portfolio
6.1.5 Takeda Recent Developments/Updates
6.2 Bayer
6.2.1 Bayer Company Information
6.2.2 Bayer Description and Business Overview
6.2.3 Bayer Recombinant Human Thrombin for Surgical Hemostasis Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Bayer Recombinant Human Thrombin for Surgical Hemostasis Product Portfolio
6.2.5 Bayer Recent Developments/Updates
6.3 CSL
6.3.1 CSL Company Information
6.3.2 CSL Description and Business Overview
6.3.3 CSL Recombinant Human Thrombin for Surgical Hemostasis Sales, Revenue and Gross Margin (2019-2024)
6.3.4 CSL Recombinant Human Thrombin for Surgical Hemostasis Product Portfolio
6.3.5 CSL Recent Developments/Updates
6.4 Grifols
6.4.1 Grifols Company Information
6.4.2 Grifols Description and Business Overview
6.4.3 Grifols Recombinant Human Thrombin for Surgical Hemostasis Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Grifols Recombinant Human Thrombin for Surgical Hemostasis Product Portfolio
6.4.5 Grifols Recent Developments/Updates
6.5 GE Healthcare
6.5.1 GE Healthcare Company Information
6.5.2 GE Healthcare Description and Business Overview
6.5.3 GE Healthcare Recombinant Human Thrombin for Surgical Hemostasis Sales, Revenue and Gross Margin (2019-2024)
6.5.4 GE Healthcare Recombinant Human Thrombin for Surgical Hemostasis Product Portfolio
6.5.5 GE Healthcare Recent Developments/Updates
6.6 Hualan Biological
6.6.1 Hualan Biological Company Information
6.6.2 Hualan Biological Description and Business Overview
6.6.3 Hualan Biological Recombinant Human Thrombin for Surgical Hemostasis Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Hualan Biological Recombinant Human Thrombin for Surgical Hemostasis Product Portfolio
6.6.5 Hualan Biological Recent Developments/Updates
6.7 Haematologic Technologies
6.7.1 Haematologic Technologies Company Information
6.7.2 Haematologic Technologies Description and Business Overview
6.7.3 Haematologic Technologies Recombinant Human Thrombin for Surgical Hemostasis Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Haematologic Technologies Recombinant Human Thrombin for Surgical Hemostasis Product Portfolio
6.7.5 Haematologic Technologies Recent Developments/Updates
6.8 Pfizer
6.8.1 Pfizer Company Information
6.8.2 Pfizer Description and Business Overview
6.8.3 Pfizer Recombinant Human Thrombin for Surgical Hemostasis Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Pfizer Recombinant Human Thrombin for Surgical Hemostasis Product Portfolio
6.8.5 Pfizer Recent Developments/Updates
6.9 Octapharma
6.9.1 Octapharma Company Information
6.9.2 Octapharma Description and Business Overview
6.9.3 Octapharma Recombinant Human Thrombin for Surgical Hemostasis Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Octapharma Recombinant Human Thrombin for Surgical Hemostasis Product Portfolio
6.9.5 Octapharma Recent Developments/Updates
6.10 Omrix Biopharmaceuticals
6.10.1 Omrix Biopharmaceuticals Company Information
6.10.2 Omrix Biopharmaceuticals Description and Business Overview
6.10.3 Omrix Biopharmaceuticals Recombinant Human Thrombin for Surgical Hemostasis Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Omrix Biopharmaceuticals Recombinant Human Thrombin for Surgical Hemostasis Product Portfolio
6.10.5 Omrix Biopharmaceuticals Recent Developments/Updates
6.11 Shanghai RAAS
6.11.1 Shanghai RAAS Company Information
6.11.2 Shanghai RAAS Description and Business Overview
6.11.3 Shanghai RAAS Recombinant Human Thrombin for Surgical Hemostasis Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Shanghai RAAS Recombinant Human Thrombin for Surgical Hemostasis Product Portfolio
6.11.5 Shanghai RAAS Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Recombinant Human Thrombin for Surgical Hemostasis Industry Chain Analysis
7.2 Recombinant Human Thrombin for Surgical Hemostasis Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Recombinant Human Thrombin for Surgical Hemostasis Production Mode & Process
7.4 Recombinant Human Thrombin for Surgical Hemostasis Sales and Marketing
7.4.1 Recombinant Human Thrombin for Surgical Hemostasis Sales Channels
7.4.2 Recombinant Human Thrombin for Surgical Hemostasis Distributors
7.5 Recombinant Human Thrombin for Surgical Hemostasis Customers
8 Recombinant Human Thrombin for Surgical Hemostasis Market Dynamics
8.1 Recombinant Human Thrombin for Surgical Hemostasis Industry Trends
8.2 Recombinant Human Thrombin for Surgical Hemostasis Market Drivers
8.3 Recombinant Human Thrombin for Surgical Hemostasis Market Challenges
8.4 Recombinant Human Thrombin for Surgical Hemostasis Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Recombinant Human Thrombin for Surgical Hemostasis Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Recombinant Human Thrombin for Surgical Hemostasis Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global Recombinant Human Thrombin for Surgical Hemostasis Market Competitive Situation by Manufacturers in 2023
Table 4. Global Recombinant Human Thrombin for Surgical Hemostasis Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Recombinant Human Thrombin for Surgical Hemostasis Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Recombinant Human Thrombin for Surgical Hemostasis Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Recombinant Human Thrombin for Surgical Hemostasis Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Recombinant Human Thrombin for Surgical Hemostasis, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Recombinant Human Thrombin for Surgical Hemostasis, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Recombinant Human Thrombin for Surgical Hemostasis, Product Type & Application
Table 12. Global Key Manufacturers of Recombinant Human Thrombin for Surgical Hemostasis, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Recombinant Human Thrombin for Surgical Hemostasis by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Human Thrombin for Surgical Hemostasis as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Recombinant Human Thrombin for Surgical Hemostasis Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Recombinant Human Thrombin for Surgical Hemostasis Sales by Region (2019-2024) & (K Units)
Table 18. Global Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Region (2019-2024)
Table 19. Global Recombinant Human Thrombin for Surgical Hemostasis Sales by Region (2025-2030) & (K Units)
Table 20. Global Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Region (2025-2030)
Table 21. Global Recombinant Human Thrombin for Surgical Hemostasis Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Recombinant Human Thrombin for Surgical Hemostasis Revenue Market Share by Region (2019-2024)
Table 23. Global Recombinant Human Thrombin for Surgical Hemostasis Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Recombinant Human Thrombin for Surgical Hemostasis Revenue Market Share by Region (2025-2030)
Table 25. North America Recombinant Human Thrombin for Surgical Hemostasis Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Recombinant Human Thrombin for Surgical Hemostasis Sales by Country (2019-2024) & (K Units)
Table 27. North America Recombinant Human Thrombin for Surgical Hemostasis Sales by Country (2025-2030) & (K Units)
Table 28. North America Recombinant Human Thrombin for Surgical Hemostasis Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Recombinant Human Thrombin for Surgical Hemostasis Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Recombinant Human Thrombin for Surgical Hemostasis Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Recombinant Human Thrombin for Surgical Hemostasis Sales by Country (2019-2024) & (K Units)
Table 32. Europe Recombinant Human Thrombin for Surgical Hemostasis Sales by Country (2025-2030) & (K Units)
Table 33. Europe Recombinant Human Thrombin for Surgical Hemostasis Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Recombinant Human Thrombin for Surgical Hemostasis Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Recombinant Human Thrombin for Surgical Hemostasis Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Recombinant Human Thrombin for Surgical Hemostasis Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Recombinant Human Thrombin for Surgical Hemostasis Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Recombinant Human Thrombin for Surgical Hemostasis Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Recombinant Human Thrombin for Surgical Hemostasis Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Recombinant Human Thrombin for Surgical Hemostasis Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Recombinant Human Thrombin for Surgical Hemostasis Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Recombinant Human Thrombin for Surgical Hemostasis Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Recombinant Human Thrombin for Surgical Hemostasis Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Recombinant Human Thrombin for Surgical Hemostasis Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa Recombinant Human Thrombin for Surgical Hemostasis Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa Recombinant Human Thrombin for Surgical Hemostasis Sales by Country (2019-2024) & (K Units)
Table 47. Middle East and Africa Recombinant Human Thrombin for Surgical Hemostasis Sales by Country (2025-2030) & (K Units)
Table 48. Middle East and Africa Recombinant Human Thrombin for Surgical Hemostasis Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa Recombinant Human Thrombin for Surgical Hemostasis Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Recombinant Human Thrombin for Surgical Hemostasis Sales (K Units) by Type (2019-2024)
Table 51. Global Recombinant Human Thrombin for Surgical Hemostasis Sales (K Units) by Type (2025-2030)
Table 52. Global Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Type (2019-2024)
Table 53. Global Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Type (2025-2030)
Table 54. Global Recombinant Human Thrombin for Surgical Hemostasis Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Recombinant Human Thrombin for Surgical Hemostasis Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Recombinant Human Thrombin for Surgical Hemostasis Revenue Market Share by Type (2019-2024)
Table 57. Global Recombinant Human Thrombin for Surgical Hemostasis Revenue Market Share by Type (2025-2030)
Table 58. Global Recombinant Human Thrombin for Surgical Hemostasis Price (US$/Unit) by Type (2019-2024)
Table 59. Global Recombinant Human Thrombin for Surgical Hemostasis Price (US$/Unit) by Type (2025-2030)
Table 60. Global Recombinant Human Thrombin for Surgical Hemostasis Sales (K Units) by Application (2019-2024)
Table 61. Global Recombinant Human Thrombin for Surgical Hemostasis Sales (K Units) by Application (2025-2030)
Table 62. Global Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Application (2019-2024)
Table 63. Global Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Application (2025-2030)
Table 64. Global Recombinant Human Thrombin for Surgical Hemostasis Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Recombinant Human Thrombin for Surgical Hemostasis Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Recombinant Human Thrombin for Surgical Hemostasis Revenue Market Share by Application (2019-2024)
Table 67. Global Recombinant Human Thrombin for Surgical Hemostasis Revenue Market Share by Application (2025-2030)
Table 68. Global Recombinant Human Thrombin for Surgical Hemostasis Price (US$/Unit) by Application (2019-2024)
Table 69. Global Recombinant Human Thrombin for Surgical Hemostasis Price (US$/Unit) by Application (2025-2030)
Table 70. Takeda Company Information
Table 71. Takeda Description and Business Overview
Table 72. Takeda Recombinant Human Thrombin for Surgical Hemostasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Takeda Recombinant Human Thrombin for Surgical Hemostasis Product
Table 74. Takeda Recent Developments/Updates
Table 75. Bayer Company Information
Table 76. Bayer Description and Business Overview
Table 77. Bayer Recombinant Human Thrombin for Surgical Hemostasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Bayer Recombinant Human Thrombin for Surgical Hemostasis Product
Table 79. Bayer Recent Developments/Updates
Table 80. CSL Company Information
Table 81. CSL Description and Business Overview
Table 82. CSL Recombinant Human Thrombin for Surgical Hemostasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. CSL Recombinant Human Thrombin for Surgical Hemostasis Product
Table 84. CSL Recent Developments/Updates
Table 85. Grifols Company Information
Table 86. Grifols Description and Business Overview
Table 87. Grifols Recombinant Human Thrombin for Surgical Hemostasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Grifols Recombinant Human Thrombin for Surgical Hemostasis Product
Table 89. Grifols Recent Developments/Updates
Table 90. GE Healthcare Company Information
Table 91. GE Healthcare Description and Business Overview
Table 92. GE Healthcare Recombinant Human Thrombin for Surgical Hemostasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. GE Healthcare Recombinant Human Thrombin for Surgical Hemostasis Product
Table 94. GE Healthcare Recent Developments/Updates
Table 95. Hualan Biological Company Information
Table 96. Hualan Biological Description and Business Overview
Table 97. Hualan Biological Recombinant Human Thrombin for Surgical Hemostasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Hualan Biological Recombinant Human Thrombin for Surgical Hemostasis Product
Table 99. Hualan Biological Recent Developments/Updates
Table 100. Haematologic Technologies Company Information
Table 101. Haematologic Technologies Description and Business Overview
Table 102. Haematologic Technologies Recombinant Human Thrombin for Surgical Hemostasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Haematologic Technologies Recombinant Human Thrombin for Surgical Hemostasis Product
Table 104. Haematologic Technologies Recent Developments/Updates
Table 105. Pfizer Company Information
Table 106. Pfizer Description and Business Overview
Table 107. Pfizer Recombinant Human Thrombin for Surgical Hemostasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Pfizer Recombinant Human Thrombin for Surgical Hemostasis Product
Table 109. Pfizer Recent Developments/Updates
Table 110. Octapharma Company Information
Table 111. Octapharma Description and Business Overview
Table 112. Octapharma Recombinant Human Thrombin for Surgical Hemostasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Octapharma Recombinant Human Thrombin for Surgical Hemostasis Product
Table 114. Octapharma Recent Developments/Updates
Table 115. Omrix Biopharmaceuticals Company Information
Table 116. Omrix Biopharmaceuticals Description and Business Overview
Table 117. Omrix Biopharmaceuticals Recombinant Human Thrombin for Surgical Hemostasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Omrix Biopharmaceuticals Recombinant Human Thrombin for Surgical Hemostasis Product
Table 119. Omrix Biopharmaceuticals Recent Developments/Updates
Table 120. Shanghai RAAS Company Information
Table 121. Shanghai RAAS Description and Business Overview
Table 122. Shanghai RAAS Recombinant Human Thrombin for Surgical Hemostasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Shanghai RAAS Recombinant Human Thrombin for Surgical Hemostasis Product
Table 124. Shanghai RAAS Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Recombinant Human Thrombin for Surgical Hemostasis Distributors List
Table 128. Recombinant Human Thrombin for Surgical Hemostasis Customers List
Table 129. Recombinant Human Thrombin for Surgical Hemostasis Market Trends
Table 130. Recombinant Human Thrombin for Surgical Hemostasis Market Drivers
Table 131. Recombinant Human Thrombin for Surgical Hemostasis Market Challenges
Table 132. Recombinant Human Thrombin for Surgical Hemostasis Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
Table 136. Authors List of This Report
List of Figures
Figure 1. Product Picture of Recombinant Human Thrombin for Surgical Hemostasis
Figure 2. Global Recombinant Human Thrombin for Surgical Hemostasis Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Recombinant Human Thrombin for Surgical Hemostasis Market Share by Type: 2023 & 2030
Figure 4. Based Bovine Product Picture
Figure 5. Based Human Product Picture
Figure 6. Others Product Picture
Figure 7. Global Recombinant Human Thrombin for Surgical Hemostasis Market Value by Application (2024-2030) & (US$ Million)
Figure 8. Global Recombinant Human Thrombin for Surgical Hemostasis Market Share by Application: 2023 & 2030
Figure 9. Hospitals
Figure 10. Diagnostics & Clinics
Figure 11. Academic and Research Institute
Figure 12. Global Recombinant Human Thrombin for Surgical Hemostasis Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Recombinant Human Thrombin for Surgical Hemostasis Market Size (2019-2030) & (US$ Million)
Figure 14. Global Recombinant Human Thrombin for Surgical Hemostasis Sales (2019-2030) & (K Units)
Figure 15. Global Recombinant Human Thrombin for Surgical Hemostasis Average Price (US$/Unit) & (2019-2030)
Figure 16. Recombinant Human Thrombin for Surgical Hemostasis Report Years Considered
Figure 17. Recombinant Human Thrombin for Surgical Hemostasis Sales Share by Manufacturers in 2023
Figure 18. Global Recombinant Human Thrombin for Surgical Hemostasis Revenue Share by Manufacturers in 2023
Figure 19. Global 5 and 10 Largest Recombinant Human Thrombin for Surgical Hemostasis Players: Market Share by Revenue in Recombinant Human Thrombin for Surgical Hemostasis in 2023
Figure 20. Recombinant Human Thrombin for Surgical Hemostasis Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 21. Global Recombinant Human Thrombin for Surgical Hemostasis Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Country (2019-2030)
Figure 23. North America Recombinant Human Thrombin for Surgical Hemostasis Revenue Market Share by Country (2019-2030)
Figure 24. United States Recombinant Human Thrombin for Surgical Hemostasis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Recombinant Human Thrombin for Surgical Hemostasis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Country (2019-2030)
Figure 27. Europe Recombinant Human Thrombin for Surgical Hemostasis Revenue Market Share by Country (2019-2030)
Figure 28. Germany Recombinant Human Thrombin for Surgical Hemostasis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Recombinant Human Thrombin for Surgical Hemostasis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Recombinant Human Thrombin for Surgical Hemostasis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Recombinant Human Thrombin for Surgical Hemostasis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Recombinant Human Thrombin for Surgical Hemostasis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Recombinant Human Thrombin for Surgical Hemostasis Revenue Market Share by Region (2019-2030)
Figure 35. China Recombinant Human Thrombin for Surgical Hemostasis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Recombinant Human Thrombin for Surgical Hemostasis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Recombinant Human Thrombin for Surgical Hemostasis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Recombinant Human Thrombin for Surgical Hemostasis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Recombinant Human Thrombin for Surgical Hemostasis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. China Taiwan Recombinant Human Thrombin for Surgical Hemostasis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Southeast Asia Recombinant Human Thrombin for Surgical Hemostasis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Latin America Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Country (2019-2030)
Figure 43. Mexico Recombinant Human Thrombin for Surgical Hemostasis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Brazil Recombinant Human Thrombin for Surgical Hemostasis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Argentina Recombinant Human Thrombin for Surgical Hemostasis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Colombia Recombinant Human Thrombin for Surgical Hemostasis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Middle East and Africa Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Country (2019-2030)
Figure 48. Middle East and Africa Recombinant Human Thrombin for Surgical Hemostasis Revenue Market Share by Country (2019-2030)
Figure 49. Turkey Recombinant Human Thrombin for Surgical Hemostasis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia Recombinant Human Thrombin for Surgical Hemostasis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. UAE Recombinant Human Thrombin for Surgical Hemostasis Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Global Sales Market Share of Recombinant Human Thrombin for Surgical Hemostasis by Type (2019-2030)
Figure 53. Global Revenue Market Share of Recombinant Human Thrombin for Surgical Hemostasis by Type (2019-2030)
Figure 54. Global Recombinant Human Thrombin for Surgical Hemostasis Price (US$/Unit) by Type (2019-2030)
Figure 55. Global Sales Market Share of Recombinant Human Thrombin for Surgical Hemostasis by Application (2019-2030)
Figure 56. Global Revenue Market Share of Recombinant Human Thrombin for Surgical Hemostasis by Application (2019-2030)
Figure 57. Global Recombinant Human Thrombin for Surgical Hemostasis Price (US$/Unit) by Application (2019-2030)
Figure 58. Recombinant Human Thrombin for Surgical Hemostasis Value Chain
Figure 59. Recombinant Human Thrombin for Surgical Hemostasis Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
